| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.559 | 112.623 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.559 | 112.623 |
| Total Expenses - EUR | 3.569 | 4.257 | 4.351 | 3.189 | 1.988 | 645 | 7.676 | 21.549 | 10.089 | 40.575 |
| Gross Profit/Loss - EUR | -3.569 | -4.257 | -4.351 | -3.189 | -1.988 | -645 | -7.676 | -21.549 | -5.530 | 72.048 |
| Net Profit/Loss - EUR | -3.569 | -4.257 | -4.351 | -3.189 | -1.988 | -645 | -7.676 | -21.549 | -5.530 | 68.679 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Luxdelphia Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.883 | 5.542 | 5.997 | 3.480 | 163 | 27.072 | 50.840 | 24.060 | 22.883 | 12.273 |
| Current Assets | 16.859 | 20.793 | 12.412 | 12.456 | 13.812 | 26.234 | 27.512 | 29.527 | 29.084 | 32.126 |
| Inventories | 8.687 | 11.341 | 11.165 | 11.535 | 12.992 | 18.831 | 20.894 | 22.933 | 22.747 | 17.142 |
| Receivables | 8.119 | 6.399 | 553 | 708 | 734 | 7.241 | 6.495 | 6.508 | 6.216 | 7.252 |
| Cash | 53 | 3.053 | 694 | 213 | 86 | 162 | 123 | 87 | 121 | 7.732 |
| Shareholders Funds | -5.155 | -9.359 | -13.552 | -16.493 | -18.161 | -18.462 | -25.729 | -47.357 | -52.743 | 16.239 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 27.897 | 35.695 | 31.961 | 32.429 | 32.136 | 71.768 | 104.080 | 100.945 | 104.711 | 28.161 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Luxdelphia Medical Srl